These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30450621)

  • 41. Adaptive, group sequential and decision theoretic approaches to sample size determination.
    Mehta CR; Patel NR
    Stat Med; 2006 Oct; 25(19):3250-69; discussion 3297-301, 3302-4, 3313-4, 3326-47. PubMed ID: 16927402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Group sequential designs for three-arm 'gold standard' non-inferiority trials with fixed margin.
    Schlömer P; Brannath W
    Stat Med; 2013 Dec; 32(28):4875-89. PubMed ID: 23970488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive designs undertaken in clinical research: a review of registered clinical trials.
    Hatfield I; Allison A; Flight L; Julious SA; Dimairo M
    Trials; 2016 Mar; 17(1):150. PubMed ID: 26993469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adaptive clinical trials: progress and challenges.
    Coffey CS; Kairalla JA
    Drugs R D; 2008; 9(4):229-42. PubMed ID: 18588354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modifying the design of ongoing trials without unblinding.
    Gould AL; Shih WJ
    Stat Med; 1998 Jan; 17(1):89-100. PubMed ID: 9463852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adaptive designs for clinical trial].
    Li W; He SJ; Wang Y; Cheng XR; Jia X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jun; 28(6):605-7. PubMed ID: 17939395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-stage designs in bioequivalence trials.
    Schütz H
    Eur J Clin Pharmacol; 2015 Mar; 71(3):271-81. PubMed ID: 25604509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A variational approach to optimal two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential designs with small samples: Evaluation and recommendations for normal responses.
    Nikolakopoulos S; Roes KC; van der Tweel I
    Stat Methods Med Res; 2018 Apr; 27(4):1115-1127. PubMed ID: 27342574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of number of subjects required for comparison of drug versus control in adaptive designs.
    Hu FF; Hu JH
    Ann Acad Med Singap; 2000 Sep; 29(5):565-9. PubMed ID: 11126689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal adaptive two-stage designs for early phase II clinical trials.
    Shan G; Wilding GE; Hutson AD; Gerstenberger S
    Stat Med; 2016 Apr; 35(8):1257-66. PubMed ID: 26526165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accounting for variation in the required sample size in the design of group-sequential trials.
    Grayling MJ; Mander AP
    Contemp Clin Trials; 2021 Aug; 107():106459. PubMed ID: 34082076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adaptive sample size modification in clinical trials: start small then ask for more?
    Jennison C; Turnbull BW
    Stat Med; 2015 Dec; 34(29):3793-810. PubMed ID: 26172385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adaptive design of confirmatory trials: Advances and challenges.
    Lai TL; Lavori PW; Tsang KW
    Contemp Clin Trials; 2015 Nov; 45(Pt A):93-102. PubMed ID: 26079372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.